Brief: Nikkei Says Oasis Petitions Kobayashi Pharma To Sue Executives For $67M
Dec 3 (Reuters) -
* OASIS PETITIONS KOBAYASHI PHARMA TO SUE EXECUTIVES FOR
$67M -
NIKKEI
* ACTIVIST INVESTOR OASIS MANAGEMENT HAS CALLED ON KOBAYASHI
PHARMACEUTICAL TO FILE A LAWSUIT AGAINST SEVEN PEOPLE - NIKKEI
* SUIT WOULD SEEK OVER 10 BILLION YEN TO REDRESS DAMAGES
CAUSED BY
SCANDAL CONCERNING RED YEAST SUPPLEMENT LINKED TO SCORES OF
DEATHS - NIKKEI
* PROPOSED LAWSUIT WOULD TARGET FORMER CHAIRMAN KAZUMASA
KOBAYASHI, FORMER PRESIDENT AKIHIRO KOBAYASHI, CURRENT PRESIDENT
SATOSHI YAMANE - NIKKEI
Further company coverage: 4967.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows